Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy
血清 miR-222-3p 在预测接受新辅助靶向治疗的 HER2 阳性乳腺癌患者的疗效和曲妥珠单抗诱导的心脏毒性方面是一把双刃剑
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2020.00631
Zhang, Shan; Wang, Yaohui; Wang, Yan; Peng, Jing; Yuan, Chenwei; Zhou, Liheng; Xu, Shuguang; Lin, Yanping; Du, Yueyao; Yang, Fan; Zhang, Jie; Dai, Huijuan; Yin, Wenjin; Lu, Jinsong